Inside FDA
Hier sind die wichtigsten FDA-Zulassungen der letzten sieben Tage: – **FDA Approves New Alzheimer’s Drug**: The FDA has approved a new drug for the treatment of Alzheimer’s disease, which is expected to slow the progression of the disease in its early stages. This approval marks a significant advancement in the treatment options available for Alzheimer’s patients[1]. – **Emergency Use Authorization for New COVID-19 Vaccine**: The FDA has granted Emergency Use Authorization (EUA) for a new COVID-19 vaccine developed to target emerging variants. This vaccine is expected to enhance the immune response and provide better protection against the latest strains of the virus[1]. – **Approval of a Novel Cancer Therapy**: A new cancer therapy has received FDA approval for the treatment of a specific type of leukemia. This therapy utilizes a novel mechanism of action to target and destroy cancer cells…





